A Pilot Study for Blood Based Biomarkers for Patients with Lung Cancer Receiving Radiation Therapy

T
Tim Lautenschlaeger, MD

Primary Investigator

Overview

The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.

Description

The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    lung cancer
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria
Willingness to undergo phlebotomy for research blood samples
Diagnosis of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)

Additional Information:

Updated on 27 Oct 2023. Study ID: 1606191988 (IUSCC-0580)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center